313 related articles for article (PubMed ID: 7510305)
1. Changes in insulin-like growth factor (IGF)-binding proteins after IGF-I injections in noninsulin-dependent diabetics.
Young SC; Clemmons DR
J Clin Endocrinol Metab; 1994 Mar; 78(3):609-14. PubMed ID: 7510305
[TBL] [Abstract][Full Text] [Related]
2. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
Bang P; Brismar K; Rosenfeld RG; Hall K
J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R
Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
[TBL] [Abstract][Full Text] [Related]
4. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus.
Bach MA; Chin E; Bondy CA
J Clin Endocrinol Metab; 1994 Oct; 79(4):1040-5. PubMed ID: 7525624
[TBL] [Abstract][Full Text] [Related]
5. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy.
Miell JP; Zini M; Quin JD; Jones J; Portioli I; Valcavi R
J Clin Endocrinol Metab; 1994 Nov; 79(5):1507-12. PubMed ID: 7525638
[TBL] [Abstract][Full Text] [Related]
6. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls.
Rutanen EM; Stenman S; Blum W; Kärkkäinen T; Lehtovirta P; Stenman UH
J Clin Endocrinol Metab; 1993 Jul; 77(1):199-204. PubMed ID: 7686914
[TBL] [Abstract][Full Text] [Related]
7. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans.
Lieberman SA; Bukar J; Chen SA; Celniker AC; Compton PG; Cook J; Albu J; Perlman AJ; Hoffman AR
J Clin Endocrinol Metab; 1992 Jul; 75(1):30-6. PubMed ID: 1377706
[TBL] [Abstract][Full Text] [Related]
9. Effect of short-term fasting on free/dissociable insulin-like growth factor I concentrations in normal human serum.
Bereket A; Wilson TA; Blethen SL; Fan J; Frost RA; Gelato MC; Lang CH
J Clin Endocrinol Metab; 1996 Dec; 81(12):4379-84. PubMed ID: 8954045
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.
Carroll PV; Umpleby M; Alexander EL; Egel VA; Callison KV; Sönksen PH; Russell-Jones DL
Clin Endocrinol (Oxf); 1998 Dec; 49(6):739-46. PubMed ID: 10209561
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults.
Young SC; Underwood LE; Celniker A; Clemmons DR
J Clin Endocrinol Metab; 1992 Aug; 75(2):603-8. PubMed ID: 1379258
[TBL] [Abstract][Full Text] [Related]
12. Insulin-dependent regulation of insulin-like growth factor-binding protein-1.
Snyder DK; Clemmons DR
J Clin Endocrinol Metab; 1990 Dec; 71(6):1632-6. PubMed ID: 1699966
[TBL] [Abstract][Full Text] [Related]
13. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
Clemmons DR; Moses AC; McKay MJ; Sommer A; Rosen DM; Ruckle J
J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
[TBL] [Abstract][Full Text] [Related]
14. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.
Clemmons DR; Moses AC; Sommer A; Jacobson W; Rogol AD; Sleevi MR; Allan G
Growth Horm IGF Res; 2005 Aug; 15(4):265-74. PubMed ID: 16005252
[TBL] [Abstract][Full Text] [Related]
15. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex.
Bang P; Brismar K; Rosenfeld RG
J Clin Endocrinol Metab; 1994 May; 78(5):1119-27. PubMed ID: 7513716
[TBL] [Abstract][Full Text] [Related]
16. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes.
Brismar K; Fernqvist-Forbes E; Wahren J; Hall K
J Clin Endocrinol Metab; 1994 Sep; 79(3):872-8. PubMed ID: 7521354
[TBL] [Abstract][Full Text] [Related]
17. Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus.
Gibson JM; Westwood M; Crosby SR; Gordon C; Holly JM; Fraser W; Anderson C; White A; Young RJ
J Clin Endocrinol Metab; 1995 Apr; 80(4):1369-75. PubMed ID: 7536208
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
López-Bermejo A; Khosravi J; Fernández-Real JM; Hwa V; Pratt KL; Casamitjana R; Garcia-Gil MM; Rosenfeld RG; Ricart W
Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of GH stimulation on fasting and prandial metabolism and plasma IGFs and IGF-binding proteins in lean and obese sheep.
McCann JP; Loo SC; Aalseth DL; Abribat T
J Endocrinol; 1997 Aug; 154(2):329-46. PubMed ID: 9291844
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.
Bang P; Degerblad M; Thorén M; Schwander J; Blum W; Hall K
Acta Endocrinol (Copenh); 1993 May; 128(5):397-404. PubMed ID: 7686320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
